US FDA could back Pfizer vax for children

By Lauran Neergaard and Matthew Perrone
Updated October 27 2021 - 8:22am, first published 8:16am
The US FDA will vote soon on whether to authorise children-sized doses of Pfizer's COVID vaccine.
The US FDA will vote soon on whether to authorise children-sized doses of Pfizer's COVID vaccine.

The United States has moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government advisers endorsed children-sized doses of Pfizer's shots for 5- to 11-year-olds.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options